Biochemistry and pathophysiology of human C1 inhibitor: current issues.

Suppr

超能文献

作者信息

Schapira M, de Agostini A, Schifferli J A, Colman R W

出版信息

Complement. 1985;2(2-3):111-26. doi: 10.1159/000467851.

DOI:10.1159/000467851

PMID:3910346

Abstract

摘要

相似文献

Biochemistry and pathophysiology of human C1 inhibitor: current issues.

Complement. 1985;2(2-3):111-26. doi: 10.1159/000467851.

Development of an immunochemical test to assess C1 inactivator function in human serum and its use for the diagnosis of hereditary angioedema.一种评估人血清中C1酯酶抑制物功能的免疫化学检测方法的开发及其在遗传性血管性水肿诊断中的应用。

Clin Immunol Immunopathol. 1980 Mar;15(3):465-71. doi: 10.1016/0090-1229(80)90058-6.

In vivo function of C1-inhibitor and pathophysiology of edema attack in patients with hereditary angioneurotic edema.

Adv Exp Med Biol. 1989;247B:79-86. doi: 10.1007/978-1-4615-9546-5_13.

Hereditary angioedema with normal C1-inhibitor activity in women.C1抑制剂活性正常的女性遗传性血管性水肿

Lancet. 2000 Jul 15;356(9225):213-7. doi: 10.1016/S0140-6736(00)02483-1.

[A hypothesis on hereditary angioedema as a disease state due to the excessive care by the body in preserving its health].

Lijec Vjesn. 1984 Apr;106(4):152-5.

Hereditary angioedema.遗传性血管性水肿

N Engl J Med. 1996 Jun 20;334(25):1666-7. doi: 10.1056/NEJM199606203342510.

[A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].[遗传性血管性水肿病例报告及水肿发作期间补体、C1 抑制物和蛋白酶抑制剂血清成分的研究]

Hokkaido Igaku Zasshi. 1987 May;62(3):497-500.

[A case of hereditary angioneurotic edema provoked by functional insufficiency of C1-inactivator].[1例由C1酯酶抑制物功能不全引发的遗传性血管性水肿]

Ter Arkh. 1989;61(6):116-9.

Autoimmune angioedema: a new role for autoantibody in disease pathogenesis.自身免疫性血管性水肿：自身抗体在疾病发病机制中的新作用。

Autoimmunity. 1990;7(2-3):181-7. doi: 10.3109/08916939008993390.

Autoantibodies in angioneurotic edema.血管性水肿中的自身抗体。

Clin Rev Allergy Immunol. 1998 Fall;16(3):207-10. doi: 10.1007/BF02737630.

引用本文的文献

Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation.在猪自体肾移植模型中，补体抑制可改善移植结果。

J Transl Med. 2016 Sep 23;14(1):277. doi: 10.1186/s12967-016-1013-7.

[Microcirculation and hemostasis in inflammatory processes. Modulation by administration of physiologic protease inhibitors as a therapeutic approach].[炎症过程中的微循环与止血。通过给予生理性蛋白酶抑制剂进行调节作为一种治疗方法]

Med Klin (Munich). 1997 Jul 15;92(7):426-31. doi: 10.1007/BF03042575.

Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.大剂量腹腔内注射抑肽酶治疗对急性重症胰腺炎补体激活及急性期反应的影响

J Gastroenterol. 1996 Oct;31(5):702-9. doi: 10.1007/BF02347620.

Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation.骨髓移植后血管渗漏综合征患者C1酯酶抑制剂的活性

Ann Hematol. 1993 Jul;67(1):17-21. doi: 10.1007/BF01709661.

C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.C1抑制剂替代疗法用于脓毒性休克和高剂量白细胞介素-2诱导的血管渗漏综合征。

Intensive Care Med. 1993;19 Suppl 1:S19-28. doi: 10.1007/BF01738946.

The structural basis for neutrophil inactivation of C1 inhibitor.中性粒细胞使C1抑制剂失活的结构基础。

Biochem J. 1989 Feb 15;258(1):193-8. doi: 10.1042/bj2580193.

Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.获得性C1抑制剂（C1-INH）Ⅱ型缺乏症。C1-INH替代疗法及患者C1-INH和抗C1-INH自身抗体分析。

J Clin Invest. 1989 Jun;83(6):1794-9. doi: 10.1172/JCI114084.

Proteolytic inactivation of plasma C1- inhibitor in sepsis.脓毒症中血浆C1抑制物的蛋白水解失活

J Clin Invest. 1989 Aug;84(2):443-50. doi: 10.1172/JCI114185.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验